Topic
Next-Generation Sequencing (NGS)
4 Podcasts on BackTable
Episode # 83 • 29 Sept 2026
Molecular-Driven Therapies in Colorectal Cancer
Which molecular alterations in colorectal cancer now change treatment and how quickly do you need the results to make the right call? On this episode of BackTable Tumor Board, Dr. Jun Gong interviews Dr. Ibrahim Sahin and Dr. Sandra Algaze about the latest advances in molecular-driven therapy across adjuvant and metastatic settings. They cover aspirin in PI3K-altered disease, the shift toward early next-generation sequencing, and the operational realities of systematic profiling at diagnosis.
More on Next-Generation Sequencing (NGS)
Loading recent podcasts…
Tumor Board # 83
Sep 28, 2026
with Dr. Sandra Algaze, Dr. Ibrahim Sahin, Dr. Jun Gong
Which molecular alterations in colorectal cancer now change treatment and how quickly do you need the results to make...
Tumor Board # 58
May 4, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Tumor Board # 74
Jul 27, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
Tumor Board # 41
Dec 29, 2025
with Dr. Shubham Pant, Dr. Jonathan Mizrahi
Metastatic pancreatic cancer is no longer a ‘one size fits all’ diagnosis. In this episode of the BackTable Tumor Board...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.